Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms, Castration-Resistant

Explore clinical trials studying Prostatic Neoplasms, Castration-Resistant. Study availability and eligibility vary by location and protocol.

36 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms, Castration-Resistant trial results

Recruiting

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

NCT06353386

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • UCSD Moores Cancer Center ( Site 0039) La Jolla, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0044) Los Angeles, California, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center-Cancer Research Services ( Site 0051) Miami, Florida, United States
  • University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0049) Baltimore, Maryland, United States
View all 77 locations
View Trial Details
Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT07225946

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Arizona Clinical Trials Chandler, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
  • University Of California San Diego La Jolla, California, United States
View all 152 locations
View Trial Details
Recruiting

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT07719361

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
View Trial Details
Recruiting

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

NCT07717268

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Hospital Universitario Miguel Servet Zaragoza, Aragon, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Instituto Catalán de Oncología Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Basurto Bilbao, Basque Country, Spain
View all 15 locations
View Trial Details
Recruiting

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

NCT04868604

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • East Jefferson General Hospital River Ridge, Louisiana, United States
  • BAMF Health Grand Rapids, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

NCT06190899

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Centre Jean Perrin Clermont-Ferrand, France
  • Institut Paoli-Calmettes Marseille, France
  • Centre Antoine Lacassagne Nice, France
View all 13 locations
View Trial Details
Recruiting

HTL0039732 in Participants With Advanced Solid Tumours

NCT05944237

Conditions
Adenoma, Colonic Diseases, Colorectal Neoplasms, +61 more
Locations
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
  • Clatterbridge Cancer Centre Liverpool, United Kingdom
  • Guy's Hospital London, United Kingdom
View Trial Details

Related conditions